⌘K

Home/Filings/4/0001387131-12-002276

4//SEC Filing

Tamir Biotechnology, Inc. 4

Accession 0001387131-12-002276

CIK 0000708717operating

View on SEC.gov Company Profile

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 3:07 PM ET

Size

5.6 KB

Accession

0001387131-12-002276

Insider Transaction Report

Form 4

Period: 2012-07-23

Tamir Biotechnology, Inc.ACEL

KENYON LAWRENCE A

CEO, CFO

Transactions

Award
Common Stock (Right to Buy)
2012-07-23+400,000→ 400,000 total
Exercise: $0.04Exp: 2022-07-23→ Common Stock (400,000 underlying)

Footnotes (2)

[F1]Issued under the Company's 2004 Stock Incentive Plan and qualified under Rule 16b-3(d)
[F2]25% of these options vest and become exercisable immediately, the grant date; 25% vest and become exercisable January 23, 2013; 25% vest and become exercisable July 23, 2013; and 25% vest and become exercisable January 23, 2014.

Documents

1 file

4
kenyon-form4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Tamir Biotechnology, Inc.

CIK 0000708717

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000708717

Filing Metadata

Form type: 4
Filed: Jul 24, 8:00 PM ET
Accepted: Jul 25, 3:07 PM ET
Size: 5.6 KB

View on SEC.gov